Article content

Top News Stories For November 13 2017

The day’s top news stories from stocks on the GuerillaStockTrading watch list.

Apple Inc. (AAPL)

TASER International, Inc. (AAXN)

Abbott Laboratories (ABT)

Acacia Communications, Inc. (ACIA)


BioDelivery Sciences International, Inc. (BDSI)

Citigroup Inc. (C)

Chipotle Mexican Grill, Inc. (CMG)

Credit Suisse Group (CS)

Delta Air Lines, Inc. (DAL)

Deciphera Pharmaceuticals, Inc. (DCPH)

Walt Disney Company (The) (DIS)

Exelixis, Inc. (EXEL)

Facebook, Inc. (FB)

Global Blood Therapeutics, Inc. (GBT)

Gilead Sciences, Inc. (GILD)

  • (11/13) As Gilead’s Outlook Dims, Argus Downgrades – Biotech stocks are given to high volatility, given several risks confronting the sector, namely FDA decisions, clinical trial results, competitive pressure and drugs falling off patents. Gilead Sciences, …
  • (11/13) Gilead: Falling Sales+Higher Spending=Lower Profits – Gilead Sciences (GILD) is trending lower today, along with biotech in general, after Argus downgraded the stock. Analyst David Toung cut his rating on Gilead from Buy to Hold, citing concerns about increasing R&D spending at a time when sales from its blockbuster franchise is waning. Toung writes that he’s concerned about the steepening decline of its hepatitis C products, as well as “flattening” HIV sales, which account for some 68% of the company’s revenues.
  • (11/12) 3 Top Biotech Stocks for 2018 – Celgene Corp., Juno Therapeutics, and Cara Therapeutics are three biotech stocks to watch in 2018.
  • (11/13) Why Argus Is Taking a Step Back on Gilead Sciences –
  • (11/13) Analysis of Industry Group Rank Keep Gilead Sciences (GILD) a Sell – InvestorPlace – Stock Market News, Stock Advice & Trading Tips Gilead Sciences Inc (NASDAQ:GILD) is classified as a constituent of the 349 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. GILD’s market value is $96.4 billion which falls in the top decile in its industry group. The ranking for GILD by Portfolio Grader places it 229 among the 349 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 535 among the 782 companies in the sector, and number 3,354 in the nearly 5,000 company Portfolio Grader universe. The post Analysis of Industry Group Rank Keep Gilead Sciences (GILD) a Sell appeared first on InvestorPlace.
  • (11/13) Top Analyst Upgrades and Downgrades: Best Buy, Equifax, Gilead, MongoDB, NVIDIA, Rio Tinto, Teva, UPS and More

Glu Mobile Inc. (GLUU)

Alphabet Inc. (GOOGL)

Goldman Sachs Group, Inc. (The) (GS)

Granite Construction Incorporated (GVA)

Huntington Ingalls Industries, Inc. (HII)

IAC/InterActiveCorp (IAC)

International Business Machines Corporation (IBM)

Internap Corporation (INAP)

Liberty Global PLC (LBTYA)

Microchip Technology Incorporated (MCHP)

The Madison Square Garden Company (MSG)

  • (11/13) Madison Square Garden CEO David O’Connor steps down –
  • (11/13) The Madison Square Garden Company Announces Senior Management Changes – NEW YORK, Nov. 13, 2017 (GLOBE NEWSWIRE) — The Madison Square Garden Company (NYSE:MSG) today announced that David O’Connor has stepped down as President and Chief Executive Officer, effective immediately. James Dolan, Executive Chairman, has assumed the additional role of interim Chief Executive Officer. About The Madison Square Garden CompanyThe Madison Square Garden Company (MSG) is a world leader in live sports and entertainment experiences.  The company presents or hosts …Full story available on

Newfield Exploration Company (NFX)

NVIDIA Corporation (NVDA)

Novartis AG (NVS)

  • (11/12) Novartis posts eye drug data amid play for Eylea’s turf – Novartis’s (NOVN.S) bid to move in on Bayer’s (BAYGn.DE) and Regeneron’s (REGN.O) eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker’s new RTH258 drug showed less disease activity than those on its rivals’ drug Eylea. Active disease was observed in 23.5 percent of RTH258 patients versus 33.5 percent of Eylea patients at 16 weeks, Novartis said, of its investigational treatment for wet age-related macular degeneration (AMD), where abnormal, leaky blood vessels can cause blindness. A second, similar study found active disease in 21.9 percent of RTH258 patients versus 31.4 percent of those on Eylea for the condition affecting 20-25 million people worldwide.
  • (11/12) Better Buy: Exelixis, Inc. vs. Novartis AG – Which stock wins in a head-to-head matchup between a rising biotech star and an established big pharma leader?, Inc. (OSTK)

Smart Global Holdings Inc (SGH)

Square, Inc. (SQ)

Switch, Inc. (SWCH)

  • (11/13) Nintendo (NTDOY) to Increase Production of Switch on High Demand – InvestorPlace – Stock Market News, Stock Advice & Trading Tips Nintendo (NTDOY) is rumored to increase production of Switch gaming console on the back of high demand from consumers. The post Nintendo (NTDOY) to Increase Production of Switch on High Demand appeared first on InvestorPlace.

Vipshop Holdings Limited (VIPS)

Vulcan Materials Company (VMC)

Vistra Energy Corp. (VST)

  • (11/13) Vistra Energy Corp. – Value Analysis (NYSE:VST) : November 13, 2017 – Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Vistra Energy Corp. a score of 67. Our analysis is based on comparing Vistra Energy Corp. with the following peers – Northland Power Inc., NextEra Energy Partners LP, NRG Yield, Inc. Class C and Pampa Energia SA (NPIFF-US, NEP-US, NYLD-US and PAMP-AR). Investment Outlook Vistra Energy Corp. … Read more (Read more…)

Weibo Corporation (WB)

Wipro Limited (WIT)

SPDR S&P Biotech (XBI)



Zions Bancorporation (ZION)

  • (11/13) ETFs with exposure to Zions Bancorporation : November 13, 2017 – Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Zions Bancorporation Here are 5 ETFs with the largest exposure to ZION-US. Comparing the performance and risk of Zions Bancorporation with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name … Read more (Read more…)
  • (11/13) Nevada State Bank Wins Best of Las Vegas, Sweeping State Contests – LAS VEGAS, Nov. 13, 2017 /PRNewswire/ — Being named the best bank in any city is an honor, but in 2017 Nevada State Bank has accomplished the extraordinary feat of winning a top honor in the state’s three metropolitan areas: Las Vegas, Reno and Elko. “We are extremely proud that clients across the state of Nevada have named us as their favorite bank,” said President and CEO Terry Shirey. “We’ve been serving Nevada families and businesses since 1959.
  • (11/13) Zions Bancorporation Enters Oversold Territory
  • (11/13) Opus Bank Names New Chief Financial Officer

Picture of SOFI artificial intelligence

SOFI AI For Premium Members

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.